2,550
Views
30
CrossRef citations to date
0
Altmetric
Research Article

LncRNA HIF2PUT inhibited osteosarcoma stem cells proliferation, migration and invasion by regulating HIF2 expression

, , &
Pages 1342-1348 | Received 10 Dec 2018, Accepted 12 Mar 2019, Published online: 10 Apr 2019

References

  • Ottaviani G, Jaffe N. The epidemiology of osteosarcoma. Cancer Treat Res. 2009;152:3–13.
  • Wu PK, Chen WM, Chen CF, et al. Primary osteogenic sarcoma with pulmonary metastasis: clinical results and prognostic factors in 91 patients, Jpn J Clin Oncol. 2009;39:514–522.
  • Vadaie N, Morris KV. Long antisense non-coding RNAs and the epigenetic regulation of gene expression. Biomol Concepts. 2013;4:411–415.
  • Zhao X, Ping W, Jing I, et al. Gas5 exerts tumor-suppressive functions in human glioma cells by targeting miR-222. Mol Ther. 2015;23:1899.
  • Ma C, Shi X, Zhu Q, et al. The growth arrest-specific transcript 5 (GAS5): a pivotal tumor suppressor long noncoding RNA in human cancers. Tumor Biol. 2016;37:1437.
  • Wang Y, Yao J, Meng H, et al. A novel long non-coding RNA, hypoxia-inducible factor-2α promoter upstream transcript, functions as an inhibitor of osteosarcoma stem cells in vitro. Mol Med Rep. 2015;11:2534–2540.
  • Yan Y, Liu F, Han L, et al. HIF-2α promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating Wnt and Notch pathways. J Exp Clin Cancer Res. 2018;37:256.
  • Sun JC, He F, Yi W, et al. High expression of HIF-2α and its anti-radiotherapy effect in lung cancer stem cells. Genet Mol Res. 2015;14:18110–18120.
  • Johansson E, Grassi ES, Pantazopoulou V, et al. CD44 interacts with HIF-2α to modulate the hypoxic phenotype of perinecrotic and perivascular glioma cells. Cell Rep. 2017;20:1641–1653.
  • Yan L, Wu X, Yin X, et al. LncRNA CCAT2 promoted osteosarcoma cell proliferation and invasion. J Cell Mol Med. 2018;22:2592–2599.
  • Feng Y, Liu X, Li X, et al. LncRNA TUG1 is upregulated and promotes cell proliferation in osteosarcoma. Open Medicine. 2016;11:163–167.
  • Zhou Y, Xia L, Wang H, et al. Cancer stem cells in progression of colorectal cancer. Oncotarget. 2018;70:33403–33415.
  • Brown H, Tellez-Gabriel M, Heymann D. Cancer stem cells in osteosarcoma: stem cells and osteosarcoma. Cancer Lett. 2017;386:189–195.
  • Qu H, Xue Y, Lian W, et al. Melatonin inhibits osteosarcoma stem cells by suppressing SOX9-mediated signaling. Life Sci. 2018;207:253–264.
  • Yao J, Li J, Geng P, et al. Knockdown of a HIF-2alpha promoter upstream long noncoding RNA impairs colorectal cancer stem cell properties in vitro through HIF-2alpha downregulation. Onco Targets Ther. 2015;8:3467–3474.
  • Li W, He X, Xue R, et al. Combined over-expression of the hypoxia-inducible factor 2α gene and its long non-coding RNA predicts unfavorable prognosis of patients with osteosarcoma. Pathol Res Pract. 2016;212:861–866.
  • Preker P, Almvig K, Christensen MS, et al. PROMoter uPstream Transcripts share characteristics with mRNAs and are produced upstream of all three major types of mammalian promoters. Nucleic Acids Res. 2011;39:7179–7193.
  • Taft RJ, Kaplan CD, Simons C, et al. Evolution, biogenesis and function of promoter-associated RNAs. Cell Cycle. 2009;8:2332–2338.
  • Yao J, Li J, Geng P, et al. Knockdown of a HIF-2α promoter upstream long noncoding RNA impairs colorectal cancer stem cell properties in vitro through HIF-2α downregulation. Onco Targets Ther. 2015;8:3467–3474.
  • Li ZH, Dou PC, Liu T, et al. Application of long noncoding RNAs in osteosarcoma: biomarkers and therapeutic targets. Cell Physiol Biochem. 2017;42:1407–1419.